OBI Pharma (4174) — Capital Reinvestment Ratio

Latest as of June 2013: 0.12x

OBI Pharma (4174) has a Capital Reinvestment Ratio of 0.12x as of June 2013, meaning it reinvests 0% of its operating cash flow (NT$50.26 Million) in capital expenditures (NT$5.80 Million). See 4174 net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.12x

Capex / Operating Cash Flow

Operating Cash Flow

NT$50.26 Million

TWD

Capital Expenditures

NT$5.80 Million

TWD

Data as of

Jun 2013

Most recent filing

Annual Capital Reinvestment Ratio for OBI Pharma (None–None)

Year-by-year Capital Reinvestment Ratio for OBI Pharma from None to None. For live market cap and broader valuation context, see 4174 market cap.

Year	Reinvestment Ratio	Operating CF (TWD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow